Surrounded by barbed wire and an electric fence, marijuana plants flourish under the bright sun on a farm in a mountainous area outside Rio de Janeiro.
Yet this farm has nothing to do with drug trafficking. It belongs to a pioneering Brazilian nongovernmental organization (NGO) engaged in the production of medical cannabis to help people with seizures.
Margarete Brito, a lawyer by training, first started growing cannabis several years ago to relieve the seizures of her daughter, Sofia, now 12, who has epilepsy.
Photo: AFP
After seeing her condition improve, Brito decided to help other people, too. So she founded the Medical Cannabis Research and Patient Support Association (APEPI), which produces artisanal therapeutic oils made from cannabis to help people with conditions similar to her daughter’s.
That work has required a lot of effort, as growing marijuana remains illegal in Brazil.
“If we follow the letter of the law, nothing authorizes us to do that,” Brito said.
However, she and her husband, Marcos Langenbach, were able to obtain an unprecedented judicial authorization to cultivate cannabis for medical purposes in 2016.
Today, their farm — about two hours by car from the Brazilian capital — has 2,000 plants growing there to help people with severe autism, multiple sclerosis and epilepsy.
Despite initial suspicion and pushback from some, Brito said the endeavor enjoys support in Brazil.
“We have real social legitimacy. That’s what protects us,” Brito said.
On a recent visit to the farm, agricultural engineer Diogo Fonseca made his way among marijuana plants growing in large black pots and marked with the names of their different varieties: Purple Wreck, Schanti, Doctor, Harle Tsu, Solar and CBG.
These plants are used to produce therapeutic oils that meet the needs of each patient, depending on whether they require a higher or lower dose of cannabidiol, a non-psychotropic substance with a relaxing effect.
Using a pocket microscope, Fonseca examines each plant to assess the ideal time to pick.
In April, armed police with sniffer dogs raided the farm, after a person who had worked on renovating its laboratory reported APEPI to the authorities.
“A lot of people have prejudices,” Brito said. “We explain how our project works to everyone, but this person believed that we were drug traffickers and informed against us,” farm manager Manoel Caetano said.
The police eventually realized the farm was a medical cannabis plantation, apologized and left, Brito said.
APEPI has forged partnerships with respected scientific institutions, such as the Oswaldo Cruz Foundation and the University of Campinas. It has grown fivefold over the past two years and now counts 1,500 members.
Among them is Gabriel Guerra, 19, who has a severe form of autism and cerebral palsy. When he was eight, he would have 60 seizures a day.
“But when he started to take the custom oil” — a few drops three times a day — “the attacks stopped,” said his father, Ricardo Guerra.
“He started to have more independence, looking for ways to communicate,” Guerra said.
Thanks to APEPI, the products have become much more accessible: 150 reais (US$28.12) for a 30ml bottle, while imported products can cost anywhere from 600 reais to 3,000 reais.
APEPI is now awaiting a court decision that they hope will allow the farm to increase its production to 10,000 plants from next year.
However, the group is not very optimistic about the prospect of medical cannabis being legalized any time soon — Brazilian President Jair Bolsonaro has already said that he would veto a bill being debated in the Brazilian National Congress.
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Singapore-based ride-hailing and delivery giant Grab Holdings Ltd has applied for regulatory approval to acquire the Taiwan operations of Germany-based Delivery Hero SE's Foodpanda in a deal valued at about US$600 million. Grab submitted the filing to the Fair Trade Commission on Friday last week, with the transaction subject to regulatory review and approval, the company said in a statement yesterday. Its independent governance structure would help foster a healthy and competitive market in Taiwan if the deal is approved, Grab said. Grab, which is listed on the NASDAQ, said in the filing that US-based Uber Technologies Inc holds about 13 percent of
Taiwan is open to joining a global liquefied natural gas (LNG) program if one is created, but on the condition that countries provide delivery even in a scenario where there is a conflict with China, an energy department official said yesterday. While Taiwan’s priority is to have enough LNG at home, the nation is open to exploring potential strategic reserves in other countries such as Japan or South Korea, Energy Administration Deputy Director-General Chen Chung-hsien (陳崇憲) said. While the LNG market does not have a global reserve for emergencies like that of oil, the concept has been raised a few times —
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
RSS